MeThreeSixty Launches GLP-1 Dose Tracking and FutureMe Moment

CARY, NC, UNITED STATES, October 14, 2026 /CourierPR/ -- MeThreeSixty, the mobile 3D body scanning app developed by Size Stream, has introduced GLP-1 Dose Tracking and FutureMe Moment to enhance user engagement and support in digital health journeys. This update aims to simplify the tracking process for GLP-1 users, who can now log their medication history alongside weight, body composition, and 3D body scans in one convenient app.

GLP-1 Dose Tracking allows users to record the names, doses, and personal notes of their GLP-1 medication, as well as track injection sites to monitor rotation over time. This feature is particularly useful for individuals focused on weight loss, as it enables them to log their weight, body composition metrics, and 3D body scans alongside their medication history. The update builds on MeThreeSixty's existing platform, which has supported over 3 million scans from more than 1 million members.

In addition to dose tracking, MeThreeSixty has launched FutureMe Moment, a new feature designed to motivate users toward their health goals. Users can upload a headshot and enter a target weight, and the app will create an AI-generated video showing a visualization of their future selves. This feature complements FutureMe, an existing MeThreeSixty feature that lets users add or reduce weight on their current 3D model to visualize their goal body. As users continue to track their progress, each new scan provides a visual representation of how their body is changing over time.

Powered by the same scanning technology used by leading pharmaceutical firms in their clinical trials, MeThreeSixty provides an accessible alternative to complex hardware by delivering detailed body data directly through a smartphone camera. In a scan that typically takes less than a minute, the platform shares 21 body measurements along with body composition metrics such as body fat percentage and lean mass. In a peer-reviewed study published in the 3DBODY.TECH Journal in December 2025, Size Stream researchers proved that the platform's mobile body fat mass estimates closely matched DXA scans, the clinical standard for measuring body composition, with an R² value above 0.96 on a scale where 1.0 is a perfect match.

To protect user privacy, body scans are processed using anonymous silhouettes, so the full-body photos taken during a scan are not uploaded or stored in the cloud. GLP-1 Dose Tracking and FutureMe Moment are free and available now on iOS and Android. GLP-1 Dose Tracking is available in English and Spanish in every country where MeThreeSixty is offered. For more information about visualizing your health journey with MeThreeSixty, visit www.methreesixty.com.